Live Broadcast: Explore the Efficacy and Safety Data for a Treatment Option for Certain Patients With ESR1-Mutated ER+/HER2- mBC

In an upcoming broadcast, Medical Doctors Hope Rugo and Joyce O'Shaughnessy will discuss important clinical efficacy and safety data for a new treatment option for certain patients with ESR1-mutated, ER+/HER2- mBC following disease progression.

To obtain expert perspective and learn about the efficacy and safety data of this new treatment option, watch the live broadcast on April 25, 2023 and May 1, 2023. To register for the event, visit https://studio.mjhassoc.com/reach/esr1m-mbc